Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxaliplatin and Taxotere in Androgen Independent Prostate Cancer
NCT00260611Phase 2Completed
- Sponsor
- University of Pittsburgh
- Start
- Nov 2004
- Primary completion
- Sep 2007
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin, docetaxel in androgen-independent prostate cancer (AIPC), sponsored by University of Pittsburgh. Started Nov 2004; status: completed.
02
Drugs
oxaliplatindocetaxel
03
Conditions
androgen-independent prostate cancer (AIPC)
Beyond the preview
Go deeper on NCT00260611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00260611.